BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 8687336)

  • 1. Rapid repigmentation after depigmentation therapy: vitiligo treated with monobenzyl ether of hydroquinone.
    Oakley AM
    Australas J Dermatol; 1996 May; 37(2):96-8. PubMed ID: 8687336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Depigmentation therapies for normal skin in vitiligo universalis.
    AlGhamdi KM; Kumar A
    J Eur Acad Dermatol Venereol; 2011 Jul; 25(7):749-57. PubMed ID: 21054565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Depigmentation Therapies for Vitiligo.
    Grimes PE; Nashawati R
    Dermatol Clin; 2017 Apr; 35(2):219-227. PubMed ID: 28317530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Q-Switched Alexandrite Laser and Topical 20% Monobenzyl Ester of Hydroquinone Removal of Tacrolimus-Induced Repigmentation (After Complete Depigmentation With 20% Monobenzyl Ether of Hydroquinone).
    McGuinn KP; Saedi N; Green JB; Dover JS
    Dermatol Surg; 2019 May; 45(5):756-757. PubMed ID: 30893165
    [No Abstract]   [Full Text] [Related]  

  • 5. Vitiligo. Therapeutic advances.
    Jimbow K
    Dermatol Clin; 1998 Apr; 16(2):399-407. PubMed ID: 9589212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monobenzylether of hydroquinone. A retrospective study of treatment of 18 vitiligo patients and a review of the literature.
    Mosher DB; Parrish JA; Fitzpatrick TB
    Br J Dermatol; 1977 Dec; 97(6):669-79. PubMed ID: 603749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Experience in the treatment of hyperpigmentation of facial skin with hydroquinone monobenzyl ether].
    Gusarova AS; Zalem ZIa
    Vestn Dermatol Venerol; 1966 Mar; 40(3):49-52. PubMed ID: 5988245
    [No Abstract]   [Full Text] [Related]  

  • 8. Monobenzyl ether of hydroquinone and 4-tertiary butyl phenol activate markedly different physiological responses in melanocytes: relevance to skin depigmentation.
    Hariharan V; Klarquist J; Reust MJ; Koshoffer A; McKee MD; Boissy RE; Le Poole IC
    J Invest Dermatol; 2010 Jan; 130(1):211-20. PubMed ID: 19657355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PUVA treatment of vitiligo: a retrospective study of Turkish patients.
    Sahin S; Hindioğlu U; Karaduman A
    Int J Dermatol; 1999 Jul; 38(7):542-5. PubMed ID: 10440288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Depigmentation therapy in vitiligo universalis with topical 4-methoxyphenol and the Q-switched ruby laser.
    Njoo MD; Vodegel RM; Westerhof W
    J Am Acad Dermatol; 2000 May; 42(5 Pt 1):760-9. PubMed ID: 10775851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of vitiligo].
    Frenk E
    Hautarzt; 1986 Jan; 37(1):1-5. PubMed ID: 3949507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bimatoprost ophthalmic solution in facial vitiligo.
    Jha AK; Prasad S; Sinha R
    J Cosmet Dermatol; 2018 Jun; 17(3):437-440. PubMed ID: 29034590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced bleaching treatment: opportunities for immune-assisted melanocyte suicide in vitiligo.
    Webb KC; Eby JM; Hariharan V; Hernandez C; Luiten RM; Le Poole IC
    Exp Dermatol; 2014 Aug; 23(8):529-33. PubMed ID: 24840876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acceleration of repigmentation in vitiligo by topical minoxidil in patients on photochemotherapy.
    Srinivas CR; Shenoi SD; Balachandran C
    Int J Dermatol; 1990 Mar; 29(2):154-5. PubMed ID: 2323875
    [No Abstract]   [Full Text] [Related]  

  • 15. Topical monobenzyl ether of hydroquinone is an effective and safe treatment for depigmentation of extensive vitiligo in the medium term: a retrospective cohort study of 53 cases.
    Tan ES; Sarkany R
    Br J Dermatol; 2015 Jun; 172(6):1662-1664. PubMed ID: 25556887
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of nonhairy melanocytic macules by dermabrasion and topical application of 5% hydroquinone monobenzyl ether cream.
    Tezuka T; Saheki M; Kusuda S; Umemoto K
    J Am Acad Dermatol; 1993 May; 28(5 Pt 1):771-2. PubMed ID: 8496423
    [No Abstract]   [Full Text] [Related]  

  • 17. Depigmentation therapies in vitiligo.
    Gupta D; Kumari R; Thappa DM
    Indian J Dermatol Venereol Leprol; 2012; 78(1):49-58. PubMed ID: 22199060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advanced treatment modalities for vitiligo.
    Patel NS; Paghdal KV; Cohen GF
    Dermatol Surg; 2012 Mar; 38(3):381-91. PubMed ID: 22288899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful treatment of vitiligo with PUVA-pigmented autologous epidermal grafting.
    Suga Y; Butt KI; Takimoto R; Fujioka N; Yamada H; Ogawa H
    Int J Dermatol; 1996 Jul; 35(7):518-22. PubMed ID: 8809611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of narrow band ultraviolet B phototherapy as monotherapy or combination therapy for vitiligo: a meta-analysis.
    Li R; Qiao M; Wang X; Zhao X; Sun Q
    Photodermatol Photoimmunol Photomed; 2017 Jan; 33(1):22-31. PubMed ID: 27696531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.